Testing is part of an ongoing initiative to develop RFID standard for labeling and tracking the blood supply chain, from donor to recipient.
The RFID Journal recently published news about how BloodCenter of Wisconsin, in cooperation with Mediware and other industry partners, will begin testing to determine whether RFID has any harmful effects on blood products. The testing is part of an ongoing initiative to develop RFID standards for labeling and tracking blood in the global supply chain, from donor to patient.
The initiative will seek to develop a standard for RFID tag size and data layout, which it will present next month to the International Society of Blood Transfusion (ISBT) for review. The ISBT is a scientific society that helps guide research, processes and standards for blood transfusion and transfusion medicine around the world.
More than a year ago, BloodCenter of Wisconsin initiated a study intended to assess whether RFID technology could be employed to augment the ISBT 128 bar-code-based system used worldwide, and to gain additional safety and operational efficiencies and effectiveness. This study indicated that potential gains from RFID could not only support increased safety, but result in an ROI as well. Based on this assessment, the team has begun to move forward with building a prototype application for blood banks. Mediware has been a sponsoring partner since the projects’ inception.
Read story published by RFID Journal.